Bolt Biotherapeutics, Inc. (BOLT)
6.54
+0.16
(+2.51%)
USD |
NASDAQ |
Nov 06, 16:00
6.50
-0.04
(-0.61%)
After-Hours: 20:00
Bolt Biotherapeutics Total Long Term Debt (Quarterly) : 18.53M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.53M |
| March 31, 2026 | 19.35M |
| December 31, 2025 | 20.13M |
| September 30, 2025 | 20.89M |
| June 30, 2025 | 21.62M |
| March 31, 2025 | 22.31M |
| December 31, 2024 | 22.96M |
| September 30, 2024 | 15.35M |
| June 30, 2024 | 15.90M |
| March 31, 2024 | 16.68M |
| December 31, 2023 | 17.44M |
| September 30, 2023 | 18.18M |
| June 30, 2023 | 18.89M |
| March 31, 2023 | 19.57M |
| Date | Value |
|---|---|
| December 31, 2022 | 20.22M |
| September 30, 2022 | 20.86M |
| June 30, 2022 | 20.75M |
| March 31, 2022 | 21.31M |
| December 31, 2021 | 21.85M |
| September 30, 2021 | 22.52M |
| June 30, 2021 | 23.16M |
| March 31, 2021 | 9.056M |
| December 31, 2020 | 34.60M |
| September 30, 2020 | 126.06M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 7.089M |
| September 30, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Caribou Biosciences, Inc. | 24.88M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |
| Sangamo Therapeutics, Inc. | 19.33M |
| Sarepta Therapeutics, Inc. | 1.053B |